Biotek-snakken
Aktiesnakken
Genmab
Zealand Pharma
TESLA
Biotek-snakken
Bavarian Nordic
Embla Medical
Krypto
Vestas
Amerikanske aktier
Banker og Finans
Chemometec
Ennogie
AMBU
NOVO
BITCOIN
GN Store Nord
Gubra
Medico
ExpreS2ion
Grønne Aktier
Laks
Pharma
Smallcap og First North aktier
|
19/9 09:39 af exitnu |
"Handel i betalda tecknade units (”BTU”): 20 augusti – 20 september 2024."
|
|
19/9 18:34 af Henrikhot |
Saniona kommenterar godkännandet att inleda epilepsistudie (link)
|
|
|
19/9 18:37 af Henrikhot |
(link) Saniona Receives Regulatory Approval for SAN711 Biomarker Study
|
|
20/9 06:00 af ProInvestorNEWS |
ELAN : FDA Oks Zenrelia, Once-Daily Oral JAK Inhibitor For Dogs With Allergic And Atopic Dermatitis (link)
|
|
|
20/9 06:00 af ProInvestorNEWS |
Tectonic Therapeutics Announces Positive Phase 1a Results For TX45 In Treating Group 2 PH-HFpEF (link)
|
|
|
20/9 06:01 af ProInvestorNEWS |
Ascendis Pharma Prices Public Offering Of 2 Mln ADSs At $150.00/ADS (link)
|
|
|
21/9 05:32 af Fandel |
Godmorgen...
|
|
|
21/9 08:25 af ProInvestorNEWS |
FDA Approves Zevra Therapeutics' MIPLYFFA For Treatment Of Niemann-Pick Disease Type C (link)
|
|
|
23/9 05:28 af Fandel |
Godmorgen...
|
|
|
23/9 07:16 af ProInvestorNEWS |
FDA greenlights Sanofi's Sarclisa in frontline multiple myeloma (link)
|
|
|
23/9 07:18 af ProInvestorNEWS |
Sanofi gears up to seek approval of BTK inhibitor tolebrutinib in MS (link)
|
|
|
23/9 15:30 af exitnu |
Genovis Launches FabRICATOR® Xtra: Next-Generation Enzyme for Future Antibody Therapeutics
(link)
|
|
|
25/9 08:20 af exitnu |
SEB inleder bevakning på Genovis med köp och riktkurs 30 kronor - BN /Finwire
|
|
|
27/9 05:36 af Fandel |
Godmorgen...
|
|
|
27/9 06:17 af ProInvestorNEWS |
Travere Therapeutics Pauses Enrollment In Phase 3 Study Of Pegtibatinase For Manufacturing Scale-Up (link)
|
|
|
27/9 06:18 af ProInvestorNEWS |
Biomea Fusion : FDA Lifts Clinical Hold On BMF-219 For Type 1 And Type 2 Diabetes Trials; Stock Up (link)
|
|
|
27/9 06:19 af ProInvestorNEWS |
Bristol Myers Squibb's COBENFY Gains FDA Approval For Adult Schizophrenia Treatment (link)
|
|
|
27/9 06:32 af ProInvestorNEWS |
Evaxion significantly expands vaccine development collaboration with MSD (link)
|
|
|
27/9 06:33 af ProInvestorNEWS |
Evaxion sælger rettigheder til to vaccinekandidater for potentielt milliardbeløb
Det er partneren MSD, som køber retten til en vaccinekandidat mod gonoré og et ikke-offentliggjort infektionsmiddel. (Medwatch abonnement) (link)
|
|
|
27/9 06:42 af ProInvestorNEWS |
SEC Announces $40 Mln Settlement With Cassava Sciences Over Misleading Alzheimer's Trial Statements (link)
|
|
|
27/9 07:18 af ProInvestorNEWS |
AbbVie sets sights on clinical hat trick for Cerevel Parkinson's drug (link)
|
|
|
27/9 07:19 af ProInvestorNEWS |
AstraZeneca scores wider US lung cancer label for Tagrisso (link)
|
|
|
27/9 07:20 af ProInvestorNEWS |
FDA panel votes against PD-1s in gastric, oesophageal cancers with low biomarker expression (link)
|
|
|
27/9 15:56 af ProInvestorNEWS |
Lundbeck vil forstå kronisk nervesygdom bedre med nyt studie (link)
|
|
| ||
|
|
29/9 07:04 af ProInvestorNEWS |
Enliven Therapeutics Updates Positive Phase 1 Data For ELVN-001 In Chronic Myeloid Leukemia Patients (link)
|
|
|
29/9 15:08 af Stroka |
I
s Viking Therapeutics Stock a Buy? (link)
|
|
|
1/10 06:31 af ProInvestorNEWS |
Why Viking Therapeutics Stock Topped the Market Today (link)
|
|
|
1/10 07:14 af ProInvestorNEWS |
Roche upbeat on obesity as acquisitions continue pipeline refresh (link)
|
|
|
1/10 08:55 af Bjæssing09 |
Saniona med nyheder: (link)
|
|
|
3/10 06:02 af Fandel |
Godmorgen...
|
|
|
3/10 08:46 af exitnu |
God morgen :-)
|
|
|
3/10 09:16 af ProInvestorNEWS |
Lundbeck indleder studie med kandidat mod sjælden øjensygdom (link)
|
|
|
3/10 09:17 af LP90 |
Godmorgen :-)
|
|
|
4/10 06:54 af Fandel |
Godmorgen...
|
|
|
4/10 07:04 af LP90 |
Godmorgen :-)
|
|
|
4/10 07:14 af ProInvestorNEWS |
Opdivo wins FDA label expansion in perioperative NSCLC (link)
|
|
|
4/10 08:33 af exitnu |
Styrelseledamot i Genovis köper sina första aktier i bolaget - Steven Jordan har den 2 oktober köpt 5 010 aktier i bioteknikbolaget Genovis där han är styrelseledamot. Aktierna köptes till kursen 1,95 pund per aktie, vilket innebär en affär på 9 769,5 pund eller cirka 132 000 kronor. Det framgår av Finansinspektionens insynsregister. Enligt bolagets hemsida ägde han inga aktier tidigare. /Finwire Smallcap.
|
|
|
4/10 08:45 af exitnu |
Ang. Genovis Insider Ownership: Der er 6 i alt som har købt eller lagt til inden for de sidste 6 måneder.
|
|
|
7/10 09:01 af Bjæssing09 |
Nyt fra Saniona igen: (link)
|
|
|
8/10 05:32 af Fandel |
Godmorgen...
|
|
|
8/10 06:16 af ProInvestorNEWS |
Gilead Sciences : Phase 3 Data Shows 96% Reduction In HIV Infections With Lenacapavir (link)
|
|
|
8/10 06:18 af ProInvestorNEWS |
Indivior Announces FDA Grants Priority Review For SUBLOCADE Prior Approval Supplement (link)
|
|
|
8/10 06:40 af ProInvestorNEWS |
Vincerx Reports Positive Initial Clinical Data From VIP943 Phase 1 Dose-Escalation Study (link)
|
|
|
10/10 09:01 af exitnu |
Nordea höjer Genovis till köp (behåll), riktkurs 28 kronor
|
|
|
11/10 06:03 af Fandel |
Godmorgen...
|
|
|
11/10 07:07 af ProInvestorNEWS |
FDA Approves Genentech's Itovebi For Advanced Breast Cancer With PIK3CA Mutation (link)
|
|
|
12/10 06:05 af Fandel |
Godmorgen...
|
|
12/10 07:37 af Helge Larsen/PI-redaktør |
FDA Approves Pfizer's HYMPAVZI For Hemophilia A And B Treatment In Adults And Adolescents (link)
|
|
|
13/10 08:35 af Fandel |
Godmorgen...
|
|
|
14/10 06:07 af Fandel |
Godmorgen...
|